Delta-9-tetrahydrocannabinol differently affects striatal c-Fos expression following haloperidol or clozapine administration

European Journal of Pharmacology

Volumn 598, Issue 1-3, 2008, Pages 16-20

  Marchese, Giorgio ^a,b   Sanna, Angela ^b   Casu, Gianluca ^b   Casti, Paola ^b   Spada, Gabriele Pinna ^b   Ruiu, Stefania ^a,b   Pani, Luca ^a,b  

^a CNR   (Italy)

^b SARDEGNA RICERCHE   (Italy)

Author keywords

Antipsychotic; Basal ganglia; Cannabinoid; Signal transduction

Indexed keywords

CLOZAPINE; DRONABINOL; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; GENE EXPRESSION; IMMUNOREACTIVITY; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; CLOZAPINE; GENE EXPRESSION; GENES, FOS; HALOPERIDOL; IMMUNOHISTOCHEMISTRY; MALE; NEOSTRIATUM; NEURONS; PIPERIDINES; PSYCHOTROPIC DRUGS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL;

EID: 54049122884     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.08.020     Document Type: Article

References (19)

1. Alonso R., Voutsinos B., Fournier M., Labie C., Steinberg R., Souilhac J., Le Fur G., and Soubrie P. Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function. Neuroscience 91 (1999) 607-620
2. Boegman R.J., and Vincent S.R. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse 22 (1996) 70-77
3. Dragunow M., Robertson G.S., Faull R.L., Robertson H.A., and Jansen K. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37 (1990) 287-294
4. Glass M., and Felder C.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17 (1997) 5327-5333
5. Guo N., Robertson G.S., and Fibiger H.C. Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res. 588, (1992) 164-167
6. Jann M.W. Clozapine. Pharmacotherapy 11 (1991) 179-195
7. Kapur S., VanderSpek S.C., Brownlee B.A., and Nobrega J.N. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J. Pharmacol. Exp. Ther. 305 (2003) 625-631
8. Huang K.X., and Walters J.R. Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum. Neuroscience 75 (1996) 757-775
9. Hussain N., Flumerfelt B.A., and Rajakumar N. Muscarinic, adenosine A(2) and histamine H(3) receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens. Neuroscience 112 (2002) 427-438
10. Leveque J.C., Macias W., Rajadhyaksha A., Carlson R.R., Barczak A., Kang S., Li X.M., Coyle J.T., Huganir R.L., Heckers S., and Konradi C. Intracellular modulation of NMDA receptor function by antipsychotic drugs. J. Neurosci. 20 (2000) 4011-4020
11. Marchese G., Casti P., Ruiu S., Saba P., Sanna A., Casu G., and Pani L. Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications. Br. J. Pharmacol. 140 (2003) 520-526
12. Meschler J.P., and Howlett A.C. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 40 (2001) 918-926
13. Mouton P.R. Principles and Practices of Unbiased Stereology (2002), The Johns Hopkins Univ. Press., London
14. Robertson G.S., Matsumura H., and Fibiger H.C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther. 271 (1994) 1058-1066
15. Rogue P., and Vincendon G. Dopamine D2 receptor antagonists induce immediate early genes in the rat striatum. Brain Res. Bull. 29 (1992) 469-472
16. Sano K., Mishima K., Koushi E., Orito K., Egashira N., Irie K., Takasaki K., Katsurabayashi S., Iwasaki K., Uchida N., Egawa T., Kitamura Y., Nishimura R., and Fujiwara M. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons. Neuroscience 151 (2008) 320-328
17. Young C.D., Bubser M., Meltzer H.Y., and Deutch A.Y. Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation. Psychopharmacology (Berl) 144 (1999) 255-263
18. Wan W., Ennulat D.J., and Cohen B.M. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. Brain Res. 688 (1995) 95-104
19. Wirtshafter D. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics. Eur. J. Pharmacol. 358 (1998) R1-3